Effect of oxidative stress during repeated ovulation on the structure and functions of the ovary, oocytes, and their mitochondria.
We previously reported that superoxide generated in the ovary induces apoptosis of granulosa cells to break down follicular walls, thereby supporting ovulation in rodents, and suggested that oxidative stress underlies the mechanism of ovarian aging. To test this hypothesis, we successfully induced ovulation repeatedly in mice by sequentially administrating pregnant mare serum gonadotropin, human chorionic gonadotropin, and prostaglandin F2alpha. Kinetic analysis revealed that the number of ovulated oocytes decreased significantly with repeated cycles of ovulation with a concomitant decrease in the gene expression of mitochondrial transcription factor A and nuclear respiratory factor 1 and an increase in oocytes having abnormally distributed mitochondria. Repeated ovulation decreased the amounts of mitochondrial DNA and increased 8-hydroxydeoxyguanosine in oocytes. Cell culture analysis of the in vivo fertilized oocytes revealed that their maturation from two cells to blastocyst was inhibited significantly by repeated ovulation. All these events induced by repeated ovulation were suppressed by oral administration of L-carnitine. These results suggest that oxidative stress associated with ovulation underlies the mechanism of ovarian aging and that L-carnitine may have therapeutic potential in patients with infertility and increased incidence of aneuploidy and to suppress impaired maturation of zygotes frequently observed in childbearing at an advanced age.
Miyamoto
Kaori
K
Department of Biochemistry and Molecular Pathology, Osaka City University Medical School, Osaka 545-8585, Japan.
Sato
Eisuke F
EF
Kasahara
Emiko
E
Jikumaru
Mika
M
Hiramoto
Keiichi
K
Tabata
Hisae
H
Katsuragi
Miyuki
M
Odo
Satoshi
S
Utsumi
Kozo
K
Inoue
Masayasu
M
D000818:Animals; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D015237:Dinoprost / Q000008:administration & dosage; D005260:Female; D006064:Gonadotropins, Equine / Q000008:administration & dosage; D006801:Humans; D051379:Mice; D008813:Mice, Inbred ICR; D008928:Mitochondria / Q000737:chemistry / Q000378:metabolism*; D009865:Oocytes / Q000378:metabolism* / Q000648:ultrastructure; D010053:Ovary / Q000201:enzymology / Q000378:metabolism* / Q000648:ultrastructure; D010062:Ovulation Induction / Q000379:methods*; D018384:Oxidative Stress
D006063:Chorionic Gonadotropin; D006064:Gonadotropins, Equine; D015237:Dinoprost